Septerna, Inc. ( SEPN ) UBS Global Biopharma Conference 2026 November 16, 2026 9:00 AM EST
Company Participants
Jeffrey Finer - Co-Founder, CEO & Director
Liz Bhatt - President & COO
Conference Call Participants
Alice Nettleton
Presentation
Alice Nettleton
Good afternoon, everybody. Welcome to the next session at the UBS Global Biopharma Conference. I'm Alice Nettleton, one of the SMID biotech analysts at UBS. Happy to introduce the team from Septerna, Jeff Finer, CEO and Co-Founder; and Liz Bhatt, President and COO. Great to see you, Jeff and Liz. Thank you so much for joining us.
To start off, I'll hand it over to Jeff to go through some slides for a presentation for maybe 15 minutes, and then we'll have a Q&A after that.
Jeffrey Finer
Co-Founder, CEO & Director
Okay. Thanks, Alice, and thanks to the UBS team for inviting us. So for those of you who aren't familiar with Septerna, we're a company focused entirely on GPCRs or G protein-coupled receptors.…